Adalat and C. diff - a phase IV clinical study of FDA data

Summary:

C. diff is reported as a side effect among people who take Adalat (nifedipine), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Linagliptin, and have Diabetes.

The phase IV clinical study analyzes which people have C. diff when taking Adalat. It is created by eHealthMe based on reports of 20,643 people who have side effects when taking Adalat from the FDA, and is updated regularly.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

What is C. diff?

C. diff is found to be associated with 1,605 drugs and 1,776 conditions by eHealthMe. Check the latest studies of C. diff.

On Jan, 28, 2026

20,643 people reported to have side effects when taking Adalat.
Among them, 17 people (0.08%) have C. diff.

Among these 17 people:

How long have people been on Adalat when they have C. diff? *

What is the gender of people who have C. diff when taking Adalat? *

female: 52.94 %
male: 47.06 %

What is the age of people who have C. diff when taking Adalat? *

What are other drugs people take besides Adalat? *

What are other side effects people have besides C. diff? *

Fever: 5 people, 29.41%
Abdominal Pain: 4 people, 23.53%
Faeces Discolored: 4 people, 23.53%
Red Blood Cell Count Decreased: 3 people, 17.65%
Diarrhea: 3 people, 17.65%
Dyspnea (difficult or laboured breathing): 3 people, 17.65%
Haematocrit Decreased: 3 people, 17.65%
Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 3 people, 17.65%
Hyperkalemia (damage to or disease of the kidney): 3 people, 17.65%
Mean Platelet Volume Increased (more than normal average size of platelet cells in blood): 3 people, 17.65%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 23.53%
Diabetes: 4 people, 23.53%
Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 11.76%
Erysipelas (bacterial skin infection): 2 people, 11.76%
Urinary Tract Infection: 1 person, 5.88%
Thyroid Cancer: 1 person, 5.88%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 5.88%
Neuralgia (pain in one or more nerves): 1 person, 5.88%
Nerve Compression: 1 person, 5.88%
Fever: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Adalat and have C. diff?

- Check whether C. diff is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Adalat:

Adalat (20,940 reports)

C. diff treatments and more:

C. diff (13,845 reports)

Browse all side effects of Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with C. diff:

C. diff (1,605 drugs)

Browse all the conditions that are associated with C. diff:

C. diff (1,776 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Adalat) and Adalat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.